-
1
-
-
0038644536
-
Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference
-
PID: 12717402
-
Neuschwander-Tetri BA, Caldwell SH (2003) Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37:1202–1219
-
(2003)
Hepatology
, vol.37
, pp. 1202-1219
-
-
Neuschwander-Tetri, B.A.1
Caldwell, S.H.2
-
3
-
-
11144351102
-
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies
-
PID: 15629518
-
Adams LA, Sanderson S, Lindor KD, Angulo P (2005) The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 42:132–138
-
(2005)
J Hepatol
, vol.42
, pp. 132-138
-
-
Adams, L.A.1
Sanderson, S.2
Lindor, K.D.3
Angulo, P.4
-
4
-
-
10644220306
-
Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity
-
PID: 15565570
-
Browning JD, Szczepaniak LS, Dobbins R et al (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40:1387–1395
-
(2004)
Hepatology
, vol.40
, pp. 1387-1395
-
-
Browning, J.D.1
Szczepaniak, L.S.2
Dobbins, R.3
-
5
-
-
33644547706
-
Nonalcoholic fatty liver disease: from steatosis to cirrhosis
-
COI: 1:CAS:528:DC%2BD28XhvVSktLo%3D, PID: 16447287
-
Farrell GC, Larter CZ (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43:S99–S112
-
(2006)
Hepatology
, vol.43
, pp. S99-S112
-
-
Farrell, G.C.1
Larter, C.Z.2
-
6
-
-
33750606061
-
Long-term follow-up of patients with NAFLD and elevated liver enzymes
-
COI: 1:CAS:528:DC%2BD28XhtFyqsrzN, PID: 17006923
-
Ekstedt M, Franzen LE, Mathiesen UL et al (2006) Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 44:865–873
-
(2006)
Hepatology
, vol.44
, pp. 865-873
-
-
Ekstedt, M.1
Franzen, L.E.2
Mathiesen, U.L.3
-
7
-
-
77952730428
-
The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
-
PID: 20209604
-
Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN (2010) The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 51:1972–1978
-
(2010)
Hepatology
, vol.51
, pp. 1972-1978
-
-
Ascha, M.S.1
Hanouneh, I.A.2
Lopez, R.3
Tamimi, T.A.4
Feldstein, A.F.5
Zein, N.N.6
-
8
-
-
18544365700
-
Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis
-
PID: 12029634
-
Ratziu V, Bonyhay L, Di Martino V et al (2002) Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology 35:1485–1493
-
(2002)
Hepatology
, vol.35
, pp. 1485-1493
-
-
Ratziu, V.1
Bonyhay, L.2
Di Martino, V.3
-
9
-
-
77951456114
-
Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection
-
PID: 20432259
-
Starley BQ, Calcagno CJ, Harrison SA (2010) Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 51:1820–1832
-
(2010)
Hepatology
, vol.51
, pp. 1820-1832
-
-
Starley, B.Q.1
Calcagno, C.J.2
Harrison, S.A.3
-
10
-
-
80053581540
-
Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States
-
PID: 21726509
-
Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA (2011) Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 141:1249–1253
-
(2011)
Gastroenterology
, vol.141
, pp. 1249-1253
-
-
Charlton, M.R.1
Burns, J.M.2
Pedersen, R.A.3
Watt, K.D.4
Heimbach, J.K.5
Dierkhising, R.A.6
-
11
-
-
77952529040
-
A position statement on NAFLD/NASH based on the EASL 2009 special conference
-
PID: 20494470
-
Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G (2010) A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 53:372–384
-
(2010)
J Hepatol
, vol.53
, pp. 372-384
-
-
Ratziu, V.1
Bellentani, S.2
Cortez-Pinto, H.3
Day, C.4
Marchesini, G.5
-
12
-
-
84861543083
-
The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
-
PID: 22488764
-
Chalasani N, Younossi Z, Lavine JE et al (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55:2005–2023
-
(2012)
Hepatology
, vol.55
, pp. 2005-2023
-
-
Chalasani, N.1
Younossi, Z.2
Lavine, J.E.3
-
13
-
-
63349097089
-
Liver biopsy
-
PID: 19243014
-
Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD, American Association for the Study of Liver Diseases (2009) Liver biopsy. Hepatology 49:1017–1044
-
(2009)
Hepatology
, vol.49
, pp. 1017-1044
-
-
Rockey, D.C.1
Caldwell, S.H.2
Goodman, Z.D.3
Nelson, R.C.4
Smith, A.D.5
-
14
-
-
80555136061
-
Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
-
PID: 21039302
-
Musso G, Gambino R, Cassader M, Pagano G (2011) Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 43:617–649
-
(2011)
Ann Med
, vol.43
, pp. 617-649
-
-
Musso, G.1
Gambino, R.2
Cassader, M.3
Pagano, G.4
-
15
-
-
34748845382
-
Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis
-
PID: 17916549
-
Talwalkar JA, Kurtz DM, Schoenleber SJ, West CP, Montori VM (2007) Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol 5:1214–1220
-
(2007)
Clin Gastroenterol Hepatol
, vol.5
, pp. 1214-1220
-
-
Talwalkar, J.A.1
Kurtz, D.M.2
Schoenleber, S.J.3
West, C.P.4
Montori, V.M.5
-
16
-
-
84876293750
-
Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal
-
PID: 23183525
-
Machado MV, Cortez-Pinto H (2013) Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. J Hepatol 58:1007–1019
-
(2013)
J Hepatol
, vol.58
, pp. 1007-1019
-
-
Machado, M.V.1
Cortez-Pinto, H.2
-
17
-
-
77954025334
-
Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango?
-
PID: 20581229
-
Castera L, Pinzani M (2010) Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango? Gut 59:861–866
-
(2010)
Gut
, vol.59
, pp. 861-866
-
-
Castera, L.1
Pinzani, M.2
-
18
-
-
73449116035
-
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
-
COI: 1:CAS:528:DC%2BC3cXhsVCqtbg%3D, PID: 19827166
-
Promrat K, Kleiner DE, Niemeier HM et al (2010) Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 51:121–129
-
(2010)
Hepatology
, vol.51
, pp. 121-129
-
-
Promrat, K.1
Kleiner, D.E.2
Niemeier, H.M.3
-
19
-
-
77951874018
-
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis
-
COI: 1:CAS:528:DC%2BC3cXls1Oltr4%3D, PID: 20427778
-
Sanyal AJ, Chalasani N, Kowdley KV et al (2010) Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 362:1675–1685
-
(2010)
N Engl J Med
, vol.362
, pp. 1675-1685
-
-
Sanyal, A.J.1
Chalasani, N.2
Kowdley, K.V.3
-
20
-
-
80055042241
-
The role of thiazolidinediones in non-alcoholic steatohepatitis—a systematic review and meta analysis
-
COI: 1:CAS:528:DC%2BC3MXhsV2mt7zE, PID: 21703200
-
Mahady SE, Webster AC, Walker S, Sanyal A, George J (2011) The role of thiazolidinediones in non-alcoholic steatohepatitis—a systematic review and meta analysis. J Hepatol 55:1383–1390
-
(2011)
J Hepatol
, vol.55
, pp. 1383-1390
-
-
Mahady, S.E.1
Webster, A.C.2
Walker, S.3
Sanyal, A.4
George, J.5
-
21
-
-
84870496528
-
Pioglitazone and vitamin E for nonalcoholic steatohepatitis: a cost utility analysis
-
COI: 1:CAS:528:DC%2BC38XhvVSmtb3M, PID: 22707355
-
Mahady SE, Wong G, Craig JC, George J (2012) Pioglitazone and vitamin E for nonalcoholic steatohepatitis: a cost utility analysis. Hepatology 56:2172–2179
-
(2012)
Hepatology
, vol.56
, pp. 2172-2179
-
-
Mahady, S.E.1
Wong, G.2
Craig, J.C.3
George, J.4
-
22
-
-
79955944811
-
Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting
-
PID: 21482590
-
Petrou S, Gray A (2011) Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting. BMJ 342:d1766
-
(2011)
BMJ
, vol.342
, pp. d1766
-
-
Petrou, S.1
Gray, A.2
-
23
-
-
58849090967
-
Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
-
PID: 19148800
-
Hashimoto E, Yatsuji S, Tobari M et al (2009) Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. J Gastroenterol 44(Suppl 19):89–95
-
(2009)
J Gastroenterol
, vol.44
, pp. 89-95
-
-
Hashimoto, E.1
Yatsuji, S.2
Tobari, M.3
-
24
-
-
79960029926
-
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
-
COI: 1:STN:280:DC%2BC3MnlsVamsg%3D%3D, PID: 21623852
-
Vernon G, Baranova A, Younossi ZM (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34:274–285
-
(2011)
Aliment Pharmacol Ther
, vol.34
, pp. 274-285
-
-
Vernon, G.1
Baranova, A.2
Younossi, Z.M.3
-
25
-
-
85017823782
-
Guidelines for the economic evaluation of health technologies: Canada (3rd edn)
-
Canadian Agency for Drugs and Technologies in Health (2006) Guidelines for the economic evaluation of health technologies: Canada (3rd edn). Ottawa 75
-
(2006)
Ottawa 75
-
-
-
26
-
-
84863509606
-
Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: a meta-analysis
-
PID: 22278368
-
Wang QB, Zhu H, Liu HL, Zhang B (2012) Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: a meta-analysis. Hepatology 56:239–247
-
(2012)
Hepatology
, vol.56
, pp. 239-247
-
-
Wang, Q.B.1
Zhu, H.2
Liu, H.L.3
Zhang, B.4
-
27
-
-
84856968669
-
Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD
-
PID: 22119555
-
Friedrich-Rust M, Romen D, Vermehren J et al (2011) Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD. Eur J Radiol. doi:10.1016/j.ejrad.2011.10.029
-
(2011)
Eur J Radiol
-
-
Friedrich-Rust, M.1
Romen, D.2
Vermehren, J.3
-
28
-
-
77957330216
-
Reduced mortality rates following elective percutaneous liver biopsies
-
PID: 20547160
-
West J, Card TR (2010) Reduced mortality rates following elective percutaneous liver biopsies. Gastroenterology 139:1230–1237
-
(2010)
Gastroenterology
, vol.139
, pp. 1230-1237
-
-
West, J.1
Card, T.R.2
-
29
-
-
84884419004
-
From NAFLD in clinical practice to answers from guidelines
-
PID: 23751754
-
Nascimbeni F, Pais R, Bellentani S et al (2013) From NAFLD in clinical practice to answers from guidelines. J Hepatol. doi:10.1016/j.jhep.2013.05.044
-
(2013)
J Hepatol
-
-
Nascimbeni, F.1
Pais, R.2
Bellentani, S.3
-
30
-
-
57549107354
-
Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design
-
COI: 1:CAS:528:DC%2BD1cXhsFagsrbE, PID: 18804555
-
Chalasani NP, Sanyal AJ, Kowdley KV et al (2009) Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design. Contemp Clin Trials 30:88–96
-
(2009)
Contemp Clin Trials
, vol.30
, pp. 88-96
-
-
Chalasani, N.P.1
Sanyal, A.J.2
Kowdley, K.V.3
-
31
-
-
0028069441
-
Determining transition probabilities: confusion and suggestions
-
COI: 1:STN:280:DyaK2c3gtlShtQ%3D%3D, PID: 8152357
-
Miller DK, Homan SM (1994) Determining transition probabilities: confusion and suggestions. Med Decis Making 14:52–58
-
(1994)
Med Decis Making
, vol.14
, pp. 52-58
-
-
Miller, D.K.1
Homan, S.M.2
-
32
-
-
84943361780
-
-
Canadian Medical Association. Canadian Provincial Billing Guide. Health Canada, Government of Canada. Accessed July 2013
-
Canadian Medical Association. Canadian Provincial Billing Guide. Health Canada, Government of Canada. Available at http://www.cma.ca/practicemanagement/medical-billing. Accessed July 2013
-
-
-
-
33
-
-
84947067702
-
A health technology assessment of transient elastography in liver disease
-
Unit UoCHTA (ed) Alberta Health Technologies Decision Process, Alberta
-
Steadman R, Leggett L, Lorenzetti D, Noseworthy T, Rose R, Sutherland L, Clement F (2012) A health technology assessment of transient elastography in liver disease. In: Unit UoCHTA (ed) Alberta Health Technologies Decision Process, Alberta
-
(2012)
In
-
-
Steadman, R.1
Leggett, L.2
Lorenzetti, D.3
Noseworthy, T.4
Rose, R.5
Sutherland, L.6
Clement, F.7
-
34
-
-
84943366099
-
-
Barry MH (2004) Magnetic resonance imaging needs assessment.In: Health NSDo (ed) Nova Scotia pp 38
-
Barry MH (2004) Magnetic resonance imaging needs assessment.In: Health NSDo (ed) Nova Scotia pp 38
-
-
-
-
35
-
-
70449561873
-
-
CIHI, Ottawa
-
Canadian Institute for Health Information (2008) Medical imaging in Canada, 2007. CIHI, Ottawa
-
(2008)
Medical imaging in Canada, 2007
-
-
-
36
-
-
84943357897
-
-
Peviva. M30 Apoptosense ELISA. Accessed July 2013
-
Peviva. M30 Apoptosense ELISA. Available at http://www.peviva.se/m30-apoptosense-elisa_us.aspx. Accessed July 2013
-
-
-
-
38
-
-
84884977723
-
Health care costs associated with hepatocellular carcinoma: a population-based study
-
PID: 23300063
-
Thein HH, Isaranuwatchai W, Campitelli MA et al (2013) Health care costs associated with hepatocellular carcinoma: a population-based study. Hepatology 58:1375–1384
-
(2013)
Hepatology
, vol.58
, pp. 1375-1384
-
-
Thein, H.H.1
Isaranuwatchai, W.2
Campitelli, M.A.3
-
39
-
-
0036971413
-
Factors associated with the high cost of liver transplantation in adults
-
PID: 12500917
-
Taylor MC, Greig PD, Detsky AS, McLeod RS, Abdoh A, Krahn MD (2002) Factors associated with the high cost of liver transplantation in adults. Can J Surg 45:425–434
-
(2002)
Can J Surg
, vol.45
, pp. 425-434
-
-
Taylor, M.C.1
Greig, P.D.2
Detsky, A.S.3
McLeod, R.S.4
Abdoh, A.5
Krahn, M.D.6
-
40
-
-
84943357775
-
-
Bank of Canada Inflation Calculator. Accessed July 2013
-
Bank of Canada Inflation Calculator. Available at http://www.bankofcanada.ca/rates/related/inflation-calculator. Accessed July 2013
-
-
-
-
41
-
-
68949136754
-
Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network
-
PID: 19434741
-
David K, Kowdley KV, Unalp A et al (2009) Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network. Hepatology 49:1904–1912
-
(2009)
Hepatology
, vol.49
, pp. 1904-1912
-
-
David, K.1
Kowdley, K.V.2
Unalp, A.3
-
42
-
-
0035052537
-
Evaluating quality-adjusted life years: estimation of the health utility index (HUI2) from the SF-36
-
COI: 1:STN:280:DC%2BD3M3hslCgtg%3D%3D, PID: 11310943
-
Nichol MB, Sengupta N, Globe DR (2001) Evaluating quality-adjusted life years: estimation of the health utility index (HUI2) from the SF-36. Med Decis Making 21:105–112
-
(2001)
Med Decis Making
, vol.21
, pp. 105-112
-
-
Nichol, M.B.1
Sengupta, N.2
Globe, D.R.3
-
43
-
-
0037345686
-
Health-state utilities and quality of life in hepatitis C patients
-
PID: 12650799
-
Chong CA, Gulamhussein A, Heathcote EJ et al (2003) Health-state utilities and quality of life in hepatitis C patients. Am J Gastroenterol 98:630–638
-
(2003)
Am J Gastroenterol
, vol.98
, pp. 630-638
-
-
Chong, C.A.1
Gulamhussein, A.2
Heathcote, E.J.3
-
44
-
-
0035120575
-
Assessment of utilities and health-related quality of life in patients with chronic liver disease
-
COI: 1:STN:280:DC%2BD3M7ot12lsg%3D%3D, PID: 11232711
-
Younossi ZM, Boparai N, McCormick M, Price LL, Guyatt G (2001) Assessment of utilities and health-related quality of life in patients with chronic liver disease. Am J Gastroenterol 96:579–583
-
(2001)
Am J Gastroenterol
, vol.96
, pp. 579-583
-
-
Younossi, Z.M.1
Boparai, N.2
McCormick, M.3
Price, L.L.4
Guyatt, G.5
-
45
-
-
0036196936
-
Assessing health-related quality of life pre- and post-liver transplantation: a prospective multicenter study
-
PID: 11910572
-
Ratcliffe J, Longworth L, Young T et al (2002) Assessing health-related quality of life pre- and post-liver transplantation: a prospective multicenter study. Liver Transpl 8:263–270
-
(2002)
Liver Transpl
, vol.8
, pp. 263-270
-
-
Ratcliffe, J.1
Longworth, L.2
Young, T.3
-
46
-
-
47249161145
-
Health-state utilities in liver disease: a systematic review
-
PID: 18424560
-
McLernon DJ, Dillon J, Donnan PT (2008) Health-state utilities in liver disease: a systematic review. Med Decis Making 28:582–592
-
(2008)
Med Decis Making
, vol.28
, pp. 582-592
-
-
McLernon, D.J.1
Dillon, J.2
Donnan, P.T.3
-
47
-
-
77955147344
-
Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography
-
PID: 20529989
-
Yoneda M, Suzuki K, Kato S et al (2010) Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography. Radiology 256:640–647
-
(2010)
Radiology
, vol.256
, pp. 640-647
-
-
Yoneda, M.1
Suzuki, K.2
Kato, S.3
-
48
-
-
84881552256
-
Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis
-
PID: 23859217
-
Bota S, Herkner H, Sporea I et al (2013) Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis. Liver Int 33:1138–1147
-
(2013)
Liver Int
, vol.33
, pp. 1138-1147
-
-
Bota, S.1
Herkner, H.2
Sporea, I.3
-
49
-
-
77958154016
-
Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes
-
PID: 20870345
-
Sasso M, Beaugrand M, de Ledinghen V et al (2010) Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol 36:1825–1835
-
(2010)
Ultrasound Med Biol
, vol.36
, pp. 1825-1835
-
-
Sasso, M.1
Beaugrand, M.2
de Ledinghen, V.3
-
50
-
-
84856708238
-
The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan
-
COI: 1:STN:280:DC%2BC383it1aitQ%3D%3D, PID: 21920839
-
Sasso M, Miette V, Sandrin L, Beaugrand M (2012) The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan. Clin Res Hepatol Gastroenterol 36:13–20
-
(2012)
Clin Res Hepatol Gastroenterol
, vol.36
, pp. 13-20
-
-
Sasso, M.1
Miette, V.2
Sandrin, L.3
Beaugrand, M.4
-
51
-
-
84155188892
-
Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients
-
PID: 21898479
-
Myers RP, Pomier-Layrargues G, Kirsch R et al (2012) Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology 55:199–208
-
(2012)
Hepatology
, vol.55
, pp. 199-208
-
-
Myers, R.P.1
Pomier-Layrargues, G.2
Kirsch, R.3
-
52
-
-
77956015752
-
Feasibility of liver transient elastography with FibroScan using a new probe for obese patients
-
PID: 20492500
-
de Ledinghen V, Vergniol J, Foucher J, El-Hajbi F, Merrouche W, Rigalleau V (2010) Feasibility of liver transient elastography with FibroScan using a new probe for obese patients. Liver Int 30:1043–1048
-
(2010)
Liver Int
, vol.30
, pp. 1043-1048
-
-
de Ledinghen, V.1
Vergniol, J.2
Foucher, J.3
El-Hajbi, F.4
Merrouche, W.5
Rigalleau, V.6
-
53
-
-
84856968669
-
Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD
-
PID: 22119555
-
Friedrich-Rust M, Romen D, Vermehren J et al (2012) Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD. Eur J Radiol 81:e325–e331
-
(2012)
Eur J Radiol
, vol.81
, pp. e325-e331
-
-
Friedrich-Rust, M.1
Romen, D.2
Vermehren, J.3
-
54
-
-
84860389114
-
Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease
-
PID: 21256907
-
Palmeri ML, Wang MH, Rouze NC et al (2011) Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease. J Hepatol 55:666–672
-
(2011)
J Hepatol
, vol.55
, pp. 666-672
-
-
Palmeri, M.L.1
Wang, M.H.2
Rouze, N.C.3
-
55
-
-
84870374798
-
Detection of non-alcoholic steatohepatitis in patients with morbid obesity before bariatric surgery: preliminary evaluation with acoustic radiation force impulse imaging
-
COI: 1:STN:280:DC%2BC38nnsFeguw%3D%3D, PID: 22648049
-
Guzman-Aroca F, Frutos-Bernal MD, Bas A et al (2012) Detection of non-alcoholic steatohepatitis in patients with morbid obesity before bariatric surgery: preliminary evaluation with acoustic radiation force impulse imaging. Eur Radiol 22:2525–2532
-
(2012)
Eur Radiol
, vol.22
, pp. 2525-2532
-
-
Guzman-Aroca, F.1
Frutos-Bernal, M.D.2
Bas, A.3
-
56
-
-
84861912749
-
Preventing overdiagnosis: how to stop harming the healthy
-
PID: 22645185
-
Moynihan R, Doust J, Henry D (2012) Preventing overdiagnosis: how to stop harming the healthy. BMJ 344, e3502
-
(2012)
BMJ
, vol.344
-
-
Moynihan, R.1
Doust, J.2
Henry, D.3
-
57
-
-
70349770695
-
Epidemiology and natural history of non-alcoholic steatohepatitis
-
PID: 19818302
-
Argo CK, Caldwell SH (2009) Epidemiology and natural history of non-alcoholic steatohepatitis. Clin Liver Dis 13:511–531
-
(2009)
Clin Liver Dis
, vol.13
, pp. 511-531
-
-
Argo, C.K.1
Caldwell, S.H.2
-
58
-
-
79956011925
-
Progression from isolated steatosis to steatohepatitis and fibrosis in nonalcoholic fatty liver disease
-
PID: 21095517
-
Pais R, Pascale A, Fedchuck L, Charlotte F, Poynard T, Ratziu V (2010) Progression from isolated steatosis to steatohepatitis and fibrosis in nonalcoholic fatty liver disease. Gastroenterol Clin Biol. doi:10.1016/j.gcb.2010.06.004
-
(2010)
Gastroenterol Clin Biol
-
-
Pais, R.1
Pascale, A.2
Fedchuck, L.3
Charlotte, F.4
Poynard, T.5
Ratziu, V.6
-
59
-
-
75449102165
-
Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance?
-
PID: 20101746
-
Angulo P (2010) Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance? Hepatology 51:373–375
-
(2010)
Hepatology
, vol.51
, pp. 373-375
-
-
Angulo, P.1
-
60
-
-
80053649814
-
Steatosis degree, measured by morphometry, is linked to other liver lesions and metabolic syndrome components in patients with NAFLD
-
COI: 1:CAS:528:DC%2BC3MXht1Ohs7zE, PID: 21904208
-
Boursier J, Chaigneau J, Roullier V et al (2011) Steatosis degree, measured by morphometry, is linked to other liver lesions and metabolic syndrome components in patients with NAFLD. Eur J Gastroenterol Hepatol 23:974–981
-
(2011)
Eur J Gastroenterol Hepatol
, vol.23
, pp. 974-981
-
-
Boursier, J.1
Chaigneau, J.2
Roullier, V.3
-
61
-
-
85027925485
-
Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease—MRI accurately quantifies hepatic steatosis in NAFLD
-
COI: 1:STN:280:DC%2BC38ngtVGksg%3D%3D, PID: 22554256
-
Permutt Z, Le T, Peterson MR et al (2012) Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease—MRI accurately quantifies hepatic steatosis in NAFLD. Aliment Pharmacol Ther 36(1):22–29
-
(2012)
Aliment Pharmacol Ther
, vol.36
, Issue.1
, pp. 22-29
-
-
Permutt, Z.1
Le, T.2
Peterson, M.R.3
-
62
-
-
84904763226
-
Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: a meta-analysis
-
Chen J, Zhu Y, Zheng Q, Jiang J (2013) Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: a meta-analysis. Hepatol Res. doi:10.1111/hepr.12197
-
(2013)
Hepatol Res
-
-
Chen, J.1
Zhu, Y.2
Zheng, Q.3
Jiang, J.4
-
63
-
-
79956292596
-
Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography
-
PID: 21460032
-
Chen J, Talwalkar JA, Yin M, Glaser KJ, Sanderson SO, Ehman RL (2011) Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 259:749–756
-
(2011)
Radiology
, vol.259
, pp. 749-756
-
-
Chen, J.1
Talwalkar, J.A.2
Yin, M.3
Glaser, K.J.4
Sanderson, S.O.5
Ehman, R.L.6
-
64
-
-
79954494392
-
Vitamin E and all-cause mortality: a meta-analysis
-
COI: 1:CAS:528:DC%2BC3MXptVOgurw%3D, PID: 21235492
-
Abner EL, Schmitt FA, Mendiondo MS, Marcum JL, Kryscio RJ (2011) Vitamin E and all-cause mortality: a meta-analysis. Curr Aging Sci 4:158–170
-
(2011)
Curr Aging Sci
, vol.4
, pp. 158-170
-
-
Abner, E.L.1
Schmitt, F.A.2
Mendiondo, M.S.3
Marcum, J.L.4
Kryscio, R.J.5
-
65
-
-
19944427642
-
Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality
-
COI: 1:CAS:528:DC%2BD2MXjvFyqtbY%3D, PID: 15537682
-
Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E (2005) Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142:37–46
-
(2005)
Ann Intern Med
, vol.142
, pp. 37-46
-
-
Miller, E.R.1
Pastor-Barriuso, R.2
Dalal, D.3
Riemersma, R.A.4
Appel, L.J.5
Guallar, E.6
-
66
-
-
84866707482
-
Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study
-
COI: 1:CAS:528:DC%2BC38XhsVWgtb%2FJ, PID: 22878886
-
Mamtani R, Haynes K, Bilker WB et al (2012) Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study. J Natl Cancer Inst 104:1411–1421
-
(2012)
J Natl Cancer Inst
, vol.104
, pp. 1411-1421
-
-
Mamtani, R.1
Haynes, K.2
Bilker, W.B.3
-
67
-
-
84883223326
-
Comparing pioglitazone to insulin with respect to cancer, cardiovascular and bone fracture endpoints, using propensity score weights
-
COI: 1:CAS:528:DC%2BC3sXhvVSmu77M, PID: 23881565
-
Vallarino C, Perez A, Fusco G et al (2013) Comparing pioglitazone to insulin with respect to cancer, cardiovascular and bone fracture endpoints, using propensity score weights. Clin Drug Investig 33:621–631
-
(2013)
Clin Drug Investig
, vol.33
, pp. 621-631
-
-
Vallarino, C.1
Perez, A.2
Fusco, G.3
-
68
-
-
84896731000
-
Thiazolidinediones and cancer: results of a meta-analysis of randomized clinical trials
-
COI: 1:CAS:528:DC%2BC2cXislemsro%3D, PID: 23851465
-
Monami M, Dicembrini I, Mannucci E (2014) Thiazolidinediones and cancer: results of a meta-analysis of randomized clinical trials. Acta Diabetol 51:91–101
-
(2014)
Acta Diabetol
, vol.51
, pp. 91-101
-
-
Monami, M.1
Dicembrini, I.2
Mannucci, E.3
-
69
-
-
84880245463
-
Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988–1994
-
PID: 23703888
-
Lazo M, Hernaez R, Eberhardt MS et al (2013) Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988–1994. Am J Epidemiol 178:38–45
-
(2013)
Am J Epidemiol
, vol.178
, pp. 38-45
-
-
Lazo, M.1
Hernaez, R.2
Eberhardt, M.S.3
-
70
-
-
34247605492
-
Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients
-
PID: 17277038
-
Targher G, Bertolini L, Padovani R et al (2007) Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 30:1212–1218
-
(2007)
Diabetes Care
, vol.30
, pp. 1212-1218
-
-
Targher, G.1
Bertolini, L.2
Padovani, R.3
-
71
-
-
0037129380
-
Nonalcoholic fatty liver disease
-
COI: 1:CAS:528:DC%2BD38XivVOmsrY%3D, PID: 11961152
-
Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346:1221–1231
-
(2002)
N Engl J Med
, vol.346
, pp. 1221-1231
-
-
Angulo, P.1
-
73
-
-
49649091383
-
Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations
-
COI: 1:CAS:528:DC%2BD1cXpt1Sltrw%3D
-
Preiss D, Sattar N (2008) Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clin Sci (Lond) 115:141–150
-
(2008)
Clin Sci (Lond)
, vol.115
, pp. 141-150
-
-
Preiss, D.1
Sattar, N.2
-
74
-
-
78650486196
-
Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study
-
PID: 20858492
-
Williams CD, Stengel J, Asike MI et al (2011) Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140:124–131
-
(2011)
Gastroenterology
, vol.140
, pp. 124-131
-
-
Williams, C.D.1
Stengel, J.2
Asike, M.I.3
-
75
-
-
0025260531
-
Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors
-
COI: 1:STN:280:DyaK3M%2FjtlGqsQ%3D%3D, PID: 2227807
-
Wanless IR, Lentz JS (1990) Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 12:1106–1110
-
(1990)
Hepatology
, vol.12
, pp. 1106-1110
-
-
Wanless, I.R.1
Lentz, J.S.2
-
76
-
-
0024578117
-
Liver pathology in diabetes mellitus and morbid obesity. Clinical, pathological, and biochemical considerations
-
PID: 2654841
-
Silverman JF, Pories WJ, Caro JF (1989) Liver pathology in diabetes mellitus and morbid obesity. Clinical, pathological, and biochemical considerations. Pathol Annu 24(Pt 1):275–302
-
(1989)
Pathol Annu
, vol.24
, pp. 275-302
-
-
Silverman, J.F.1
Pories, W.J.2
Caro, J.F.3
-
77
-
-
9044219843
-
Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients
-
COI: 1:STN:280:DyaK287mtVOmtg%3D%3D, PID: 8565753
-
Pinto HC, Baptista A, Camilo ME, Valente A, Saragoca A, de Moura MC (1996) Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Dig Dis Sci 41:172–179
-
(1996)
Dig Dis Sci
, vol.41
, pp. 172-179
-
-
Pinto, H.C.1
Baptista, A.2
Camilo, M.E.3
Valente, A.4
Saragoca, A.5
de Moura, M.C.6
-
78
-
-
85017799859
-
WGO global guidelines nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
-
World Gastroenterology Organisation (2012) WGO global guidelines nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. p 29
-
(2012)
p 29
-
-
-
79
-
-
84859705556
-
Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up
-
PID: 22245895
-
Zelber-Sagi S, Lotan R, Shlomai A et al (2012) Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up. J Hepatol 56:1145–1151
-
(2012)
J Hepatol
, vol.56
, pp. 1145-1151
-
-
Zelber-Sagi, S.1
Lotan, R.2
Shlomai, A.3
-
80
-
-
0028875908
-
The natural history of nonalcoholic fatty liver: a follow-up study
-
COI: 1:STN:280:DyaK28%2FovVyhtQ%3D%3D, PID: 7489979
-
Teli MR, James OF, Burt AD, Bennett MK, Day CP (1995) The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 22:1714–1719
-
(1995)
Hepatology
, vol.22
, pp. 1714-1719
-
-
Teli, M.R.1
James, O.F.2
Burt, A.D.3
Bennett, M.K.4
Day, C.P.5
-
81
-
-
77953971188
-
Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years
-
PID: 20581244
-
Wong VW, Wong GL, Choi PC et al (2010) Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut 59:969–974
-
(2010)
Gut
, vol.59
, pp. 969-974
-
-
Wong, V.W.1
Wong, G.L.2
Choi, P.C.3
-
82
-
-
58849134985
-
Long-term follow-up of patients with nonalcoholic fatty liver
-
PID: 19049831
-
Rafiq N, Bai C, Fang Y et al (2009) Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol 7:234–238
-
(2009)
Clin Gastroenterol Hepatol
, vol.7
, pp. 234-238
-
-
Rafiq, N.1
Bai, C.2
Fang, Y.3
-
83
-
-
4644297019
-
Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies
-
PID: 15382171
-
Fassio E, Alvarez E, Dominguez N, Landeira G, Longo C (2004) Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies. Hepatology 40:820–826
-
(2004)
Hepatology
, vol.40
, pp. 820-826
-
-
Fassio, E.1
Alvarez, E.2
Dominguez, N.3
Landeira, G.4
Longo, C.5
-
84
-
-
14644392822
-
Histological progression of non-alcoholic fatty liver disease in Chinese patients
-
COI: 1:STN:280:DC%2BD2M%2FotVKmsw%3D%3D, PID: 15709991
-
Hui AY, Wong VW, Chan HL et al (2005) Histological progression of non-alcoholic fatty liver disease in Chinese patients. Aliment Pharmacol Ther 21:407–413
-
(2005)
Aliment Pharmacol Ther
, vol.21
, pp. 407-413
-
-
Hui, A.Y.1
Wong, V.W.2
Chan, H.L.3
-
85
-
-
79960549297
-
The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study
-
PID: 21688282
-
Bhala N, Angulo P, van der Poorten D et al (2011) The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study. Hepatology 54:1208–1216
-
(2011)
Hepatology
, vol.54
, pp. 1208-1216
-
-
Bhala, N.1
Angulo, P.2
van der Poorten, D.3
-
86
-
-
0043268063
-
Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C
-
PID: 12883486
-
Hui JM, Kench JG, Chitturi S et al (2003) Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology 38:420–427
-
(2003)
Hepatology
, vol.38
, pp. 420-427
-
-
Hui, J.M.1
Kench, J.G.2
Chitturi, S.3
-
87
-
-
33645963121
-
Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C
-
PID: 16502396
-
Sanyal AJ, Banas C, Sargeant C et al (2006) Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C. Hepatology 43:682–689
-
(2006)
Hepatology
, vol.43
, pp. 682-689
-
-
Sanyal, A.J.1
Banas, C.2
Sargeant, C.3
-
88
-
-
75449088414
-
Decreased survival of subjects with elevated liver function tests during a 28-year follow-up
-
PID: 20014114
-
Soderberg C, Stal P, Askling J et al (2010) Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 51:595–602
-
(2010)
Hepatology
, vol.51
, pp. 595-602
-
-
Soderberg, C.1
Stal, P.2
Askling, J.3
-
89
-
-
4344628555
-
The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis 8:521–533
-
McCullough AJ (2004) The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis 8:521–533, viii
-
(2004)
viii
-
-
McCullough, A.J.1
-
90
-
-
16244369103
-
Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort
-
PID: 15795889
-
Marrero JA, Fontana RJ, Barrat A et al (2005) Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology 41:707–716
-
(2005)
Hepatology
, vol.41
, pp. 707-716
-
-
Marrero, J.A.1
Fontana, R.J.2
Barrat, A.3
-
91
-
-
63049133092
-
Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005
-
PID: 19224838
-
Altekruse SF, McGlynn KA, Reichman ME (2009) Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 27:1485–1491
-
(2009)
J Clin Oncol
, vol.27
, pp. 1485-1491
-
-
Altekruse, S.F.1
McGlynn, K.A.2
Reichman, M.E.3
-
92
-
-
20344374757
-
Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients
-
COI: 1:STN:280:DC%2BD2M3lvVaqtw%3D%3D, PID: 15870713
-
Greten TF, Papendorf F, Bleck JS et al (2005) Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients. Br J Cancer 92:1862–1868
-
(2005)
Br J Cancer
, vol.92
, pp. 1862-1868
-
-
Greten, T.F.1
Papendorf, F.2
Bleck, J.S.3
-
93
-
-
34347339562
-
Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers
-
PID: 17617329
-
Lang H, Sotiropoulos GC, Brokalaki EI et al (2007) Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers. J Am Coll Surg 205:27–36
-
(2007)
J Am Coll Surg
, vol.205
, pp. 27-36
-
-
Lang, H.1
Sotiropoulos, G.C.2
Brokalaki, E.I.3
-
94
-
-
35148887206
-
Outcome of patients with hepatocellular carcinoma referred to a tertiary centre with availability of multiple treatment options including cadaveric liver transplantation
-
PID: 17919236
-
Perry JF, Charlton B, Koorey DJ et al (2007) Outcome of patients with hepatocellular carcinoma referred to a tertiary centre with availability of multiple treatment options including cadaveric liver transplantation. Liver Int 27:1240–1248
-
(2007)
Liver Int
, vol.27
, pp. 1240-1248
-
-
Perry, J.F.1
Charlton, B.2
Koorey, D.J.3
-
95
-
-
70350046669
-
Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study
-
COI: 1:CAS:528:DC%2BD1MXhtlWlu7jL, PID: 19585618
-
Feldstein AE, Wieckowska A, Lopez AR, Liu YC, Zein NN, McCullough AJ (2009) Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology 50:1072–1078
-
(2009)
Hepatology
, vol.50
, pp. 1072-1078
-
-
Feldstein, A.E.1
Wieckowska, A.2
Lopez, A.R.3
Liu, Y.C.4
Zein, N.N.5
McCullough, A.J.6
-
96
-
-
34247384560
-
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD
-
COI: 1:CAS:528:DC%2BD2sXltlWis7k%3D, PID: 17393509
-
Angulo P, Hui JM, Marchesini G et al (2007) The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45:846–854
-
(2007)
Hepatology
, vol.45
, pp. 846-854
-
-
Angulo, P.1
Hui, J.M.2
Marchesini, G.3
-
97
-
-
41349094999
-
Performance of transient elastography for the staging of liver fibrosis: a meta-analysis
-
PID: 18395077
-
Friedrich-Rust M, Ong MF, Martens S et al (2008) Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 134:960–974
-
(2008)
Gastroenterology
, vol.134
, pp. 960-974
-
-
Friedrich-Rust, M.1
Ong, M.F.2
Martens, S.3
-
98
-
-
84891889855
-
Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease—the role of transient elastography and plasma cytokeratin-18 fragments
-
COI: 1:STN:280:DC%2BC2c3jslKhtw%3D%3D, PID: 24308774
-
Kwok R, Tse YK, Wong GL et al (2014) Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease—the role of transient elastography and plasma cytokeratin-18 fragments. Aliment Pharmacol Ther 39:254–269
-
(2014)
Aliment Pharmacol Ther
, vol.39
, pp. 254-269
-
-
Kwok, R.1
Tse, Y.K.2
Wong, G.L.3
-
99
-
-
84855835833
-
Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis
-
COI: 1:STN:280:DC%2BC383jtlymtA%3D%3D, PID: 22239521
-
Friedrich-Rust M, Nierhoff J, Lupsor M et al (2012) Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepat 19:e212–e219
-
(2012)
J Viral Hepat
, vol.19
, pp. e212-e219
-
-
Friedrich-Rust, M.1
Nierhoff, J.2
Lupsor, M.3
-
100
-
-
84885959250
-
The efficiency of acoustic radiation force impulse imaging for the staging of liver fibrosis: a meta-analysis
-
PID: 23801420
-
Nierhoff J, Chavez Ortiz AA, Herrmann E, Zeuzem S, Friedrich-Rust M (2013) The efficiency of acoustic radiation force impulse imaging for the staging of liver fibrosis: a meta-analysis. Eur Radiol 23:3040–3053
-
(2013)
Eur Radiol
, vol.23
, pp. 3040-3053
-
-
Nierhoff, J.1
Chavez Ortiz, A.A.2
Herrmann, E.3
Zeuzem, S.4
Friedrich-Rust, M.5
-
101
-
-
77950619459
-
Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations
-
PID: 20063276
-
Castera L, Foucher J, Bernard PH et al (2010) Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 51:828–835
-
(2010)
Hepatology
, vol.51
, pp. 828-835
-
-
Castera, L.1
Foucher, J.2
Bernard, P.H.3
-
102
-
-
33750120876
-
Transient elastography (FibroScan) for non-invasive assessment of liver fibrosis
-
Murtagh J, Foerster V (2006) Transient elastography (FibroScan) for non-invasive assessment of liver fibrosis. Issues Emerg Health Technol 1–4
-
(2006)
Issues Emerg Health Technol
, pp. 1-4
-
-
Murtagh, J.1
Foerster, V.2
-
103
-
-
65949094613
-
An evaluation of the potential cost-effectiveness of non-invasive testing strategies in the diagnosis of significant liver fibrosis
-
PID: 19457153
-
Carlson JJ, Kowdley KV, Sullivan SD, Ramsey SD, Veenstra DL (2009) An evaluation of the potential cost-effectiveness of non-invasive testing strategies in the diagnosis of significant liver fibrosis. J Gastroenterol Hepatol 24:786–791
-
(2009)
J Gastroenterol Hepatol
, vol.24
, pp. 786-791
-
-
Carlson, J.J.1
Kowdley, K.V.2
Sullivan, S.D.3
Ramsey, S.D.4
Veenstra, D.L.5
-
105
-
-
42149189962
-
Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies
-
PID: 18433397
-
Myers RP, Fong A, Shaheen AA (2008) Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies. Liver Int 28:705–712
-
(2008)
Liver Int
, vol.28
, pp. 705-712
-
-
Myers, R.P.1
Fong, A.2
Shaheen, A.A.3
-
106
-
-
84943361716
-
-
Régie de l'assurance maladie du Québec (RAMQ). RAMQ liste de medicaments 2013. Quebec Ministry of Health and Social Services; 2013. Accessed Aug 2013
-
Régie de l'assurance maladie du Québec (RAMQ). RAMQ liste de medicaments 2013. Quebec Ministry of Health and Social Services; 2013. Available at https://www.prod.ramq.gouv.qc.ca/DPI/PO/Commun/PDF/Liste_Med/Liste_Med/liste_med_cor_2013_07_15_fr.pdf. Accessed Aug 2013
-
-
-
-
107
-
-
41649118950
-
Surveillance of cirrhosis for hepatocellular carcinoma: a cost-utility analysis
-
COI: 1:STN:280:DC%2BD1c3itl2jtw%3D%3D, PID: 18382459
-
Thompson Coon J, Rogers G, Hewson P et al (2008) Surveillance of cirrhosis for hepatocellular carcinoma: a cost-utility analysis. Br J Cancer 98:1166–1175
-
(2008)
Br J Cancer
, vol.98
, pp. 1166-1175
-
-
Thompson Coon, J.1
Rogers, G.2
Hewson, P.3
-
108
-
-
82955197321
-
Cost of a quality-adjusted life year in liver transplantation: the influence of the indication and the model for end-stage liver disease score
-
PID: 21770017
-
Aberg F, Maklin S, Rasanen P et al (2011) Cost of a quality-adjusted life year in liver transplantation: the influence of the indication and the model for end-stage liver disease score. Liver Transpl 17:1333–1343
-
(2011)
Liver Transpl
, vol.17
, pp. 1333-1343
-
-
Aberg, F.1
Maklin, S.2
Rasanen, P.3
|